JPS525764A - Production of pyrrolidone - Google Patents
Production of pyrrolidoneInfo
- Publication number
- JPS525764A JPS525764A JP51075954A JP7595476A JPS525764A JP S525764 A JPS525764 A JP S525764A JP 51075954 A JP51075954 A JP 51075954A JP 7595476 A JP7595476 A JP 7595476A JP S525764 A JPS525764 A JP S525764A
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolidone
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752528664 DE2528664A1 (en) | 1975-06-27 | 1975-06-27 | PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS525764A true JPS525764A (en) | 1977-01-17 |
Family
ID=5950059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51075954A Pending JPS525764A (en) | 1975-06-27 | 1976-06-26 | Production of pyrrolidone |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS525764A (en) |
| AT (1) | AT365575B (en) |
| BE (1) | BE843505A (en) |
| CH (1) | CH623809A5 (en) |
| DE (1) | DE2528664A1 (en) |
| DK (1) | DK287476A (en) |
| ES (1) | ES449095A1 (en) |
| FR (1) | FR2316943A1 (en) |
| GB (1) | GB1553595A (en) |
| IL (1) | IL49916A0 (en) |
| LU (1) | LU75235A1 (en) |
| NL (1) | NL7606773A (en) |
| SE (1) | SE7607331L (en) |
| ZA (1) | ZA763802B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| JP2011116768A (en) * | 2002-05-14 | 2011-06-16 | Allergan Inc | 8-azaprostaglandin analog as agent for lowering intraocular pressure |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE423813B (en) * | 1976-08-06 | 1982-06-07 | Pfizer | PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES |
| US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
| PL356662A1 (en) * | 1999-12-22 | 2004-06-28 | Pfizer Products Inc. | Ep4 receptor selective agonists in the treatment of osteoporosis |
| NZ525164A (en) | 2000-11-27 | 2005-04-29 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis |
| ES2254726T3 (en) | 2001-07-16 | 2006-06-16 | F. Hoffmann-La Roche Ag | PROSTAGLANDINE ANALOGS AS EP4 RECEIVING AGONISTS. |
| EP1408961B1 (en) | 2001-07-16 | 2007-07-11 | F. Hoffmann-La Roche Ag | 2 pyrrolidone derivatives as prostanoid agonists |
| CN101921220B (en) | 2001-07-23 | 2013-05-22 | 小野药品工业株式会社 | Pharmaceutical compositions for treating diseases with bone mass loss having EP4 agonist as the active ingredient |
| WO2003077910A1 (en) * | 2002-03-18 | 2003-09-25 | Pfizer Products Inc. | Methods of treatment with selective ep4 receptor agonists |
| BRPI0406717A (en) | 2003-01-10 | 2005-12-20 | Hoffmann La Roche | Compound, pharmaceutical composition comprising the same, method of treating a disease in a mammal, use of the compound and process for its production |
| US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| HUE031885T2 (en) | 2012-07-19 | 2017-08-28 | Cayman Chemical Co Inc | Difluorolactam compositions for ep4-mediated osteo related diseases and conditions |
| ES2635635T3 (en) | 2013-03-15 | 2017-10-04 | Cayman Chemical Company, Incorporated | Difluorolactam compounds as selective agonists of the EP4 receptor for use in the treatment of diseases and conditions mediated by EP4 |
| WO2014144500A2 (en) | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
| US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
| KR20160048054A (en) | 2013-07-19 | 2016-05-03 | 카이맨 케미칼 컴파니 인코포레이티드 | Methods, systems, and compositions for promoting bone growth |
-
1975
- 1975-06-27 DE DE19752528664 patent/DE2528664A1/en not_active Withdrawn
-
1976
- 1976-06-22 ES ES449095A patent/ES449095A1/en not_active Expired
- 1976-06-22 NL NL7606773A patent/NL7606773A/en not_active Application Discontinuation
- 1976-06-24 SE SE7607331A patent/SE7607331L/en unknown
- 1976-06-24 LU LU75235A patent/LU75235A1/xx unknown
- 1976-06-24 CH CH809976A patent/CH623809A5/en not_active IP Right Cessation
- 1976-06-25 GB GB26564/76A patent/GB1553595A/en not_active Expired
- 1976-06-25 IL IL49916A patent/IL49916A0/en unknown
- 1976-06-25 DK DK287476A patent/DK287476A/en unknown
- 1976-06-25 AT AT0467976A patent/AT365575B/en active
- 1976-06-25 ZA ZA763802A patent/ZA763802B/en unknown
- 1976-06-26 JP JP51075954A patent/JPS525764A/en active Pending
- 1976-06-28 BE BE168390A patent/BE843505A/en not_active IP Right Cessation
- 1976-06-28 FR FR7619563A patent/FR2316943A1/en active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002024647A1 (en) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| JP2011116768A (en) * | 2002-05-14 | 2011-06-16 | Allergan Inc | 8-azaprostaglandin analog as agent for lowering intraocular pressure |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2316943A1 (en) | 1977-02-04 |
| GB1553595A (en) | 1979-09-26 |
| IL49916A0 (en) | 1976-08-31 |
| LU75235A1 (en) | 1977-03-16 |
| FR2316943B1 (en) | 1978-11-03 |
| AT365575B (en) | 1982-01-25 |
| BE843505A (en) | 1976-12-28 |
| ES449095A1 (en) | 1977-12-16 |
| DK287476A (en) | 1976-12-28 |
| CH623809A5 (en) | 1981-06-30 |
| ZA763802B (en) | 1977-05-25 |
| DE2528664A1 (en) | 1977-01-13 |
| NL7606773A (en) | 1976-12-29 |
| ATA467976A (en) | 1981-06-15 |
| SE7607331L (en) | 1976-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS51118763A (en) | Production of alkylenecarbonate | |
| JPS5236683A (en) | Production of riphamycin | |
| JPS5212162A (en) | Production of phenylindoline | |
| JPS51141897A (en) | Production of riphamycin | |
| JPS5251392A (en) | Production of triazolopyridazinones | |
| JPS51131873A (en) | Production of 44loneralkyll 55cyanoooxazole | |
| JPS527958A (en) | Production of 22 pyrrolidone | |
| JPS5248698A (en) | Production of riphamycin | |
| JPS525762A (en) | Production of betaa acylpyrol | |
| JPS5273865A (en) | Production of novel pyrrolidone | |
| JPS51115473A (en) | Production of lower alkylimidazolecarboxylate | |
| JPS5289667A (en) | Production of nnsubstituted spirolaltam | |
| JPS5219695A (en) | Production of tetrahydrothiopyranopyrazols | |
| JPS5227758A (en) | Production of 22methyll 11naphthol | |
| JPS5248689A (en) | Production of pyrazolopyridineketones | |
| JPS51115465A (en) | Production of 55phenyll 22framidoxime | |
| JPS51130543A (en) | Production of instant onigiri | |
| JPS5248662A (en) | Production of 44hydroxymethyll 22pyrorysines | |
| JPS5273858A (en) | Production of phospholenee 11calcogenite | |
| JPS51138679A (en) | Production of 22aryll2hh benzotriazole | |
| JPS5246100A (en) | Production of pyrazolopyridopirimidine | |
| JPS5212991A (en) | Production of bioprotein | |
| JPS5236690A (en) | Production of 33methoxymethlcephalosporin | |
| JPS51128997A (en) | Production of pyrazolopyridineketones | |
| JPS5277057A (en) | Production of nnalkenyll22 aminomethylpyrolidines* |